Evidence map›Paper›PMID 37241017›Full record

ArticleJournal of personalized medicine2023

Sentinel Lymph Node Impact on the Quality of Life of Patients with Endometrial Cancer.

Virginia García-Pineda, Alicia Hernández, Sonia Garrido-Mallach, Elena Rodríguez-González, María Alonso-Espías, Myriam Gracia, Rocío Arnedo, Ignacio Zapardiel

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Virginia García-PinedaGynaecologic Oncology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0002-6434-3630
Alicia HernándezGynaecologic Oncology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
Sonia Garrido-MallachGynaecologic Oncology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
Elena Rodríguez-GonzálezObstetrics and Gynaecology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0003-1152-4486
María Alonso-EspíasGynaecologic Oncology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
Myriam GraciaGynaecologic Oncology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0002-8717-5270
Rocío ArnedoObstetrics and Gynaecology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
Ignacio ZapardielGynaecologic Oncology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.ORCID 0000-0002-9175-7767
Hospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGiven the improvement in the surgical treatment of endometrial cancer with the inclusion of sentinel lymph node biopsy (SLNB), our aim was to evaluate the impact of this minimally invasive and tailored nodal assessment on patients' quality of life (QoL).

methodsThis was a cross-sectional study conducted in a single-centre, tertiary-level hospital. Patients diagnosed with preoperative early-stage endometrial cancer, who underwent primary surgical treatment between August 2015 and November 2021, were included. The enrolled patients were divided into two cohorts according to the nodal staging performed: the first group underwent only SLNB (SLNB group); the second group underwent pelvic and/or para-aortic lymphadenectomy (LND group). We evaluated the overall QoL using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life core 30-item questionnaire (EORTC QLQ-C30) and a sexual health questionnaire (EORTC SHQ-C20). The scores were compared between the groups.

resultsNinety patients were enrolled in the study: 61 (67.8%) in the SLNB group and 29 (32.2%) in the LND group. In the LND group, 24 (82.7%) patients underwent pelvic and para-aortic LND, while 5 (17.3%) patients underwent pelvic LND. The assessment of the functional scales showed better results for the SLNB group than for the LND group, with a significantly lower impact on physical status (8.2% vs. 25%, respectively;

conclusionsThe implementation of a surgical technique with SLNB improved patients' overall QoL by increasing their well-being in the functional and symptom spheres.

Indexed as

endometrial cancernodal assessmentoverall quality of lifesentinel lymph node biopsysexual quality of life

Identifiers

PMID37241017
PMCPMC10221888
OpenAlexW4377103579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.